The Novartis Korea CEO, listed government support, growing per-capita consumption, and an aging population, as the key drivers of Korea’s bio-pharmaceutical industry, in a recent interview with the JoongAng Daily. Korea is one of a few key emerging pharmaceutical markets in the world, according to Peter Jager, president of Novartis Korea. In a recent interview,...
Read More »